Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Psychopharmacology
|
June 7, 2011
Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
Karen L Marquis, Thomas A Comery, Flora Jow, et al.
Brain Research
|
April 3, 2020
Antinociceptive effects of potent, selective and brain penetrant muscarinic M<sub>4</sub> positive allosteric modulators in rodent pain models
Steven M Grauer, Raul Sanoja, Dominic Poulin, et al.
Molecular and Cellular Neurosciences
|
October 3, 2009
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
Sheree F Logue, Steven M Grauer, Janet Paulsen, et al.
Journal of Neuro-Oncology
|
April 10, 2008
Selective cancer-germline gene expression in pediatric brain tumors
Joannes F M Jacobs, Oliver M Grauer, Francis Brasseur, et al.
Genome Medicine
|
June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
I-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Neuro-Oncology
|
February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma
Bastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Leukemia
|
July 26, 2012
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia
M Konantz, M C André, M Ebinger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2009
Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia
Steven M Grauer, Virginia L Pulito, Rachel L Navarra, et al.
Genome Medicine
|
September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
Michael Heming, Svea Haessner, Jolien Wolbert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2006
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity
Karen L Marquis, Annmarie L Sabb, Sheree F Logue, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Psychopharmacology
|
June 7, 2011
Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
Karen L Marquis, Thomas A Comery, Flora Jow, et al.
Brain Research
|
April 3, 2020
Antinociceptive effects of potent, selective and brain penetrant muscarinic M<sub>4</sub> positive allosteric modulators in rodent pain models
Steven M Grauer, Raul Sanoja, Dominic Poulin, et al.
Molecular and Cellular Neurosciences
|
October 3, 2009
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
Sheree F Logue, Steven M Grauer, Janet Paulsen, et al.
Journal of Neuro-Oncology
|
April 10, 2008
Selective cancer-germline gene expression in pediatric brain tumors
Joannes F M Jacobs, Oliver M Grauer, Francis Brasseur, et al.
Genome Medicine
|
June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
I-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Neuro-Oncology
|
February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma
Bastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Leukemia
|
July 26, 2012
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia
M Konantz, M C André, M Ebinger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2009
Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia
Steven M Grauer, Virginia L Pulito, Rachel L Navarra, et al.
Genome Medicine
|
September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
Michael Heming, Svea Haessner, Jolien Wolbert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2006
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity
Karen L Marquis, Annmarie L Sabb, Sheree F Logue, et al.
Page
of 8